Menu

CTI BioPharma Corp. CTIC

Full chart Compare
Set alert

Price alert · CTIC

All alert types
9.10 0.00 (+0.00%)

Jun 23, 2023, 3:58 PM EDT

9.09 Day range 9.10

52-week range unavailable

Revenue & Expenses

Revenue → Gross Profit: $50.43MGross Profit → Expenses: $50.43MRevenue → Cost of Revenue: $3.51MExpenses → Selling, General & Admin: $84.83MExpenses → Research & Development: $36.90MExpenses → Other Operating Expenses: $8.51MExpenses → Interest Expense: $13.14MExpenses → Other Expenses: $56.00KNet Loss → Expenses: $92.99MGross Profit$50.43MNet Loss$92.99MCost of Revenue$3.51MExpenses$143.43MSelling, General & Admin$84.83MResearch & Development$36.90MOther Operating Expenses$8.51MInterest Expense$13.14MOther Expenses$56.00KRevenue$53.95M

Latest period ending Dec 31, 2022 · select a line to chart its full history

CTIC annual income statement
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
53.95M003.35M26.29M
50.43M003.35M26.29M
-79.80M-95.33M-47.77M-40.71M-32.90M
-92.99M-97.91M-52.45M-40.02M-29.32M
-0.81-1.09-0.74-0.69-0.52
CTIC annual balance sheet
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
30.42M65.45M40.39M31.14M36.44M
125.92M72.43M58.24M46.28M89.83M
143.50M68.67M18.21M28.35M36.89M
109.08M47.38M4.46M9.27M14.08M
-17.58M3.77M40.03M23.69M58.69M
CTIC annual cash flow
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
-81.19M-84.89M-42.20M-27.82M-39.82M
-73.85M12.00M-9.62M28.13M-30.49M
120.02M97.94M61.07M-5.61M63.49M
-35.03M25.05M9.25M-5.29M-6.78M